Viridian Therapeutics (VRDN)
(Delayed Data from NSDQ)
$15.02 USD
-0.10 (-0.66%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $15.01 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.98 | -3.19% |
Earnings Summary
For their last quarter, Viridian Therapeutics (VRDN) reported earnings of -$1.02 per share, missing the Zacks Consensus Estimate of -$0.87 per share. This reflects a negative earnings surprise of 17.24%. Look out for VRDN's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.98 per share, reflecting a year-over-year increase of 10.09%.
Earnings History
Price & Consensus
Zacks News for VRDN
Strength Seen in Viridian Therapeutics (VRDN): Can Its 8.7% Jump Turn into More Strength?
VRDN: What are Zacks experts saying now?
Zacks Private Portfolio Services